12/31/2019

Cash & ST Marketable Securities               $1,533.3
Total Liabilities (ST & LT)                            $1,512.4
Interest Expense (annual est.)                    $60.3
Return on Equity                                           24.1%
*millions

No concerns about financial position…

Date	Sales (millions)	% Chg.
3/2018	184.4	30%
6/2018	242.5	42%
9/2018	266.7	44%
12/2018	338	53%
3/2019	280.5	52%
6/2019	336.4	39%
9/2019	396.3	49%
12/2019	462.8	37%

Investor Concerns

It’s expensive to continually update and develop new products in the medical device space.

Other larger medical device companies are entering this space. Abbot Laboratories is the latest

Investor Confidence

The popularity of their device continues to rise among doctors and end users. Sales continue to increase quarter over quarter. They have reaffirmed full year guidance for 2020.

https://investors.dexcom.com/node/19051/html#s0F6B1E295F4D5BC1802315D142DABB8A